Letter to the Editor of Clinical Breast Cancer, on “Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review,” Conducted by Michelle Bradbury and Collaborators and Published in Clinical Breast Cancer April Vol 22 no.4 e362-e373, 2022

Saved in:

Bibliographic Details
Published in:	Clinical breast cancer Vol. 23; no. 3; pp. e109 - e111
Main Authors:	de Oliveira, Luciana Mello, Garcia, Helana Ortiz, Curvello, Karine Duarte, Rebelatto, Taiane Francielli, Dal Pizzol, Tatiane da Silva
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-04-2023
Subjects:	Antineoplastic Agents, Hormonal - therapeutic use Aromatase Inhibitors - therapeutic use Breast Neoplasms - drug therapy Female Humans Tamoxifen - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23 ObjectType-Undefined-2
ISSN:	1526-8209 1938-0666
DOI:	10.1016/j.clbc.2022.12.018